Breast Cancer Prevention
Review examines therapeutic value of selective estrogen receptor modulators in breast cancer
Published in Women's Health Weekly, February 16th, 2006
"Despite the beneficial effects of estrogens in women's health, there is a plethora of evidence that suggest an important role for these hormones, particularly 17 beta-estradiol (E2 ), in the development and progression of breast cancer. Most estrogenic responses are mediated by estrogen receptors (ERs), either ERalpha or ERbeta, which are members of the nuclear receptor superfamily of ligand-dependent transcription factors," explained investigators from the Fox Chase Cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Identification of all sentinel nodes may reduce risk of breast cancer recurrence - Gynecological Cancer
Nedaplatin exhibited strong antitumor activity in gynecological carcinomas - Human Papillomavirus
Human papillomavirus in adolescents could lead to genital abnormalities - Obesity
Smoking during early pregnancy increases risk of obesity in young children - Venous Thromboembolism
Longer endogenous estrogen exposure increases risk of venous thromboembolism - Addiction Medicine
Cash for sterilization program for drug and alcohol addicts increases paid incentives to $300 - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
